A Long-Awaited Sunrise for Bali Residents and Investors:
The realization of Bali as a major international medical tourism hub.
For years, we've watched and anticipated, and now, it's finally here: Bali is poised to become a major international medical tourism hub.
Beyond Tourism: Addressing the critical healthcare needs of aging populations, particularly cancer patients across Asia, Australia, and New Zealand where over half the worlds population resides.
Asia and Australia over Half Worlds Population
The Indonesian government's ambitious plan to develop a world-class international hospital complex is no longer just a dream.
This isn't just about attracting tourists; it's about offering cutting-edge medical treatments, particularly for the growing concerns of aging populations – diabetes, arthritis, and most crucially, cancer, a disease that tragically impacts millions across Asia , Australia and New Zealand.
A Powerful Synergy: Indonesian Government and Singaporean Expertise Unite:
The Indonesian government and esteemed medical professionals from Singapore have recognized a powerful synergy. This collaboration isn't just a win for Indonesia; it's a beacon of hope for patients worldwide.
For too long, the reality has been stark: for serious medical conditions, many have had to seek treatment in Singapore or, more recently, Kuala Lumpur – often at a significant financial cost.
For too long, the reality has been stark: for serious medical conditions, many have had to seek treatment in Singapore or, more recently, Kuala Lumpur – often at a significant financial cost.
 |
| Brand New Bali International Hospital |
Impressive Credentials: Singaporean Medical Pioneers Arrive: Initial research reveals extensive experience and outstanding reputations.
The first four doctors announced hail from a prestigious Singaporean Hospital Clinic.
A preliminary look at their biographies reveals extensive experience and impressive credentials.
Biography of First International Doctors to Practice new Bali International Hospital.
Here's a glimpse of my initial findings on the doctors from Singapore, all associated with the same reputable clinic and boasting extensive backgrounds:While we haven't yet delved into their patient testimonials, the initial profiles are highly promising, and we intend to conduct further research in the near future.
Dr. Robert Lim:
Biography
Dr Robert Lim is a graduate of both the University of St Andrews and University of Edinburgh where he obtained his medical degree (MBChB).
He then moved to New York where he completed his postgraduate training in Internal Medicine followed by Hematology and Medical Oncology at The New York Hospital – Cornell University Medical College and Memorial Sloan Kettering Cancer Center.
In addition to his American Board certifications in Internal Medicine, Medical Oncology and Hematology, Dr Lim is also a Fellow of the Royal College of Physicians in Edinburgh.
After returning to Singapore in 1998, he has developed special clinical interest in biliary tract cancer, colorectal cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer and accepts referrals for all cancer types.
Besides his skills in clinical care, he has co-authored several major pivotal studies in colon cancer and pancreatic cancer that have influenced clinical practice. From 2005 to 2011, he was the Head of the Department of Hematology-Oncology at the National University Cancer Institute, Singapore (NCIS).
After returning to Singapore in 1998, he has developed special clinical interest in biliary tract cancer, colorectal cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer and accepts referrals for all cancer types.
Besides his skills in clinical care, he has co-authored several major pivotal studies in colon cancer and pancreatic cancer that have influenced clinical practice. From 2005 to 2011, he was the Head of the Department of Hematology-Oncology at the National University Cancer Institute, Singapore (NCIS).
In particular, the focus in developing new drug treatments and enhancing the understanding of the unique problem for Asians with cancer has helped many patients and their families.
He has been a member of the Specialist Training Committee in Medical Oncology, instrumental in training many doctors both in internal medicine and oncology, providing invaluable mentorship and guidance. Amongst his many varied responsibilities, he has served as an Associate Director of NCIS and is a previous council member of Dover Park Hospice, chairing their medical professional audit committee.
Dr Lim is conversant in English and Mandarin, and is able to support his patients in these languages.
Dr. Francis Chin Kuok Choon,
Dr Francis Chin is a Radiation Oncologist with experience across both medical oncology and radiation oncology.
He is an ASEAN and Chevening scholar, receiving scholarships from the Singapore and British Government and participated in an EU sponsored MSc in radiation biology with distinction.
Dr Chin is the first student from Asia to attend this prestigious radiobiology course sponsored by the European Commission to produce experts in radiation biology and radiation oncology.
Before joining Icon, Dr Chin worked for over 20 years with the National Cancer Center in Singapore and continues to be a visiting consultant at KK Women and Children’s Hospital. He was also on the steering committee of the Viva-KKH Pediatric Brain and Solid Tumor program.
Dr Chin also holds a number of positions across Singapore. He is Deputy Chair of the Institutional Research Boards in Oncology/ Hematology at SingHealth, with concurrent appointments with HSA/DSRB IRBs. He is also a member of the SingHealth Quality Assurance Committee who look into the Clinical Risk Management across SingHealth’s cluster hospitals.
He was a member of the SingHealth NCCS Proton Therapy Implementation Committee and a lead Principal Investigator in a National Research Foundation 10 million SGD program grant for proton therapy from 2017 to 2022.
Dr Chin is passionate about the continual improvement of radiation oncology and leads several Quality Assurance Improvement projects teams, including the radiation proton development management team.
He has been a member of the Specialist Training Committee in Medical Oncology, instrumental in training many doctors both in internal medicine and oncology, providing invaluable mentorship and guidance. Amongst his many varied responsibilities, he has served as an Associate Director of NCIS and is a previous council member of Dover Park Hospice, chairing their medical professional audit committee.
Dr Lim is conversant in English and Mandarin, and is able to support his patients in these languages.
Dr. Francis Chin Kuok Choon,
Dr Francis Chin is a Radiation Oncologist with experience across both medical oncology and radiation oncology.
He is an ASEAN and Chevening scholar, receiving scholarships from the Singapore and British Government and participated in an EU sponsored MSc in radiation biology with distinction.
Dr Chin is the first student from Asia to attend this prestigious radiobiology course sponsored by the European Commission to produce experts in radiation biology and radiation oncology.
Before joining Icon, Dr Chin worked for over 20 years with the National Cancer Center in Singapore and continues to be a visiting consultant at KK Women and Children’s Hospital. He was also on the steering committee of the Viva-KKH Pediatric Brain and Solid Tumor program.
Dr Chin also holds a number of positions across Singapore. He is Deputy Chair of the Institutional Research Boards in Oncology/ Hematology at SingHealth, with concurrent appointments with HSA/DSRB IRBs. He is also a member of the SingHealth Quality Assurance Committee who look into the Clinical Risk Management across SingHealth’s cluster hospitals.
He was a member of the SingHealth NCCS Proton Therapy Implementation Committee and a lead Principal Investigator in a National Research Foundation 10 million SGD program grant for proton therapy from 2017 to 2022.
Dr Chin is passionate about the continual improvement of radiation oncology and leads several Quality Assurance Improvement projects teams, including the radiation proton development management team.
He held academic appointments as Adjunct Assistant Professor, SingHealth DUKE NUS Oncology Academic Oncology Clinical Programme (ACP) and Pediatrics ACP from 2015 to 2019. His radiation oncology projects have been selected internationally by International Atomic Energy Agency (IAEA) as one of the highlights at IAEA’s technical experts meeting.
He was the president-elect of the South East Asian Radiation Oncology Group (SEAROG) from 2017 to 2018; SEAROG comprises of the radiation oncology societies of South East Asian countries, including Indonesia, Philippines, Malaysia, Singapore, Cambodia, Myanmar and Vietnam. Since 2006 SEAROG has collaborated with ESTRO to organise local ESTRO school courses to improve the radiation expertise and training in this region. He was an editorial board member of the Royal College of Radiologist, UK and is also a recognized local and regional expert in radiation biology and a chapter author in the Oxford Textbook of Critical Care, (second edition) on radiation poisoning.
Dr Chin accepts referrals for all cancer types and is experienced across a range of cancers with particular interest in breast cancers, gynecologic conditions and gastrointestinal cancers, prostate cancers, pediatrics, soft tissue sarcomas. He is proficient in English, Mandarin, Malay, Hokkien and Cantonese, and is able to support his patients in these languages.
Dr. Patricia Kho Sunn Sunn,
Biography
With over 20 years of experience, Dr Patricia Kho is an experienced medical oncologist who is practicing at Mount Elizabeth Novena, Gleneagles and Mount Alvernia Hospital, Singapore. She has subspecialty interests in lung, head and neck, breast and gastrointestinal cancers.
Dr Kho graduated from the University of Newcastle upon Tyne, UK, and worked at the National University Hospital (NUH) in Singapore before continuing her specialist postgraduate training in Medical Oncology at the Sydney Cancer Centre, Royal Prince Alfred Hospital, (now known as Chris O’brien Lifehouse) under the mentorship of Prof Michael Boyer, Prof Stephen Clarke and Prof Alan Coates.
He was the president-elect of the South East Asian Radiation Oncology Group (SEAROG) from 2017 to 2018; SEAROG comprises of the radiation oncology societies of South East Asian countries, including Indonesia, Philippines, Malaysia, Singapore, Cambodia, Myanmar and Vietnam. Since 2006 SEAROG has collaborated with ESTRO to organise local ESTRO school courses to improve the radiation expertise and training in this region. He was an editorial board member of the Royal College of Radiologist, UK and is also a recognized local and regional expert in radiation biology and a chapter author in the Oxford Textbook of Critical Care, (second edition) on radiation poisoning.
Dr Chin accepts referrals for all cancer types and is experienced across a range of cancers with particular interest in breast cancers, gynecologic conditions and gastrointestinal cancers, prostate cancers, pediatrics, soft tissue sarcomas. He is proficient in English, Mandarin, Malay, Hokkien and Cantonese, and is able to support his patients in these languages.
Dr. Patricia Kho Sunn Sunn,
Biography
With over 20 years of experience, Dr Patricia Kho is an experienced medical oncologist who is practicing at Mount Elizabeth Novena, Gleneagles and Mount Alvernia Hospital, Singapore. She has subspecialty interests in lung, head and neck, breast and gastrointestinal cancers.
Dr Kho graduated from the University of Newcastle upon Tyne, UK, and worked at the National University Hospital (NUH) in Singapore before continuing her specialist postgraduate training in Medical Oncology at the Sydney Cancer Centre, Royal Prince Alfred Hospital, (now known as Chris O’brien Lifehouse) under the mentorship of Prof Michael Boyer, Prof Stephen Clarke and Prof Alan Coates.
She obtained her fellowship from the Royal Australasian College of Physicians (FRACP) in 2003.
Her interest in translational research in search of personalized cancer treatments, led her to work at Genome Institute of Singapore under Prof Edison Liu from 2002 to 2003. She subsequently obtained a Master of Philosophy (Medicine) from the University of Sydney with a research thesis entitled “Optimizing Adjuvant Treatment for Colorectal Cancer”.
Dr Kho returned to Sydney in 2005 and was appointed Head of the Department of Medical Oncology in Liverpool Hospital, a public teaching university hospital in Sydney. She was also the Director of the Clinical Trials unit, Clinical lecturer of University of New South Wales and a visiting scientist at the Garvan Institute of Research in Sydney.
Dr Kho is proficient in English, Mandarin, Hokkien and Cantonese, and looks forward to support her patients in these languages.
Dr. Tan Yew Oo
Biography
Dr Tan Yew Oo was the former Professor of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore (NUS), and Chief of Medicine at National University Hospital (NUH) and Head of the Division of Hematology-Oncology. He was a tenured faculty staff of NUS from 1978 till 1993 and during his tenure, he was instrumental in setting up the specialty of Medical Oncology at National University Hospital.
While maintaining a busy private practice, he continues to play an active part in medical education and healthcare issues. Currently, he serves in as in Clinical Risk Group of SingHealth, member of MediShield Life Council of Ministry of Health, member of National Advisory Committee of Cancer and member of Complaints Committee of Singapore Medical Council.
Her interest in translational research in search of personalized cancer treatments, led her to work at Genome Institute of Singapore under Prof Edison Liu from 2002 to 2003. She subsequently obtained a Master of Philosophy (Medicine) from the University of Sydney with a research thesis entitled “Optimizing Adjuvant Treatment for Colorectal Cancer”.
Dr Kho returned to Sydney in 2005 and was appointed Head of the Department of Medical Oncology in Liverpool Hospital, a public teaching university hospital in Sydney. She was also the Director of the Clinical Trials unit, Clinical lecturer of University of New South Wales and a visiting scientist at the Garvan Institute of Research in Sydney.
Dr Kho is proficient in English, Mandarin, Hokkien and Cantonese, and looks forward to support her patients in these languages.
Dr. Tan Yew Oo
Biography
Dr Tan Yew Oo was the former Professor of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore (NUS), and Chief of Medicine at National University Hospital (NUH) and Head of the Division of Hematology-Oncology. He was a tenured faculty staff of NUS from 1978 till 1993 and during his tenure, he was instrumental in setting up the specialty of Medical Oncology at National University Hospital.
While maintaining a busy private practice, he continues to play an active part in medical education and healthcare issues. Currently, he serves in as in Clinical Risk Group of SingHealth, member of MediShield Life Council of Ministry of Health, member of National Advisory Committee of Cancer and member of Complaints Committee of Singapore Medical Council.
He was also the founding Chairman of Medical Board of Farrer Park Hospital.
Dr Tan was awarded the Public Service Medal at the 2020 National Day Awards, recognizing his significant contribution to public service and healthcare in Singapore. In 2021, a professorship was named in his honour – the Tan Yew Oo Professorship in Pathology at Duke-NUS which recognizes the importance of pathology in cancer research and support long-term research and advancements in pathology.
Dr Tan has published in several medical and peer reviewed journals and has been invited to speak at regional and international medical meetings. Dr Tan is also actively involved in clinical trials and enrolls patients into clinical trials at Icon clinics.
Dr Tan accepts referrals or second opinion for all cancer types, with special clinical interests in breast cancer, gastrointestinal cancer, liver cancer, lung cancer and lymphoma. He speaks English, Mandarin, Hokkien and Malay, and is able to converse with his patients in these languages.
Dr Tan was awarded the Public Service Medal at the 2020 National Day Awards, recognizing his significant contribution to public service and healthcare in Singapore. In 2021, a professorship was named in his honour – the Tan Yew Oo Professorship in Pathology at Duke-NUS which recognizes the importance of pathology in cancer research and support long-term research and advancements in pathology.
Dr Tan has published in several medical and peer reviewed journals and has been invited to speak at regional and international medical meetings. Dr Tan is also actively involved in clinical trials and enrolls patients into clinical trials at Icon clinics.
Dr Tan accepts referrals or second opinion for all cancer types, with special clinical interests in breast cancer, gastrointestinal cancer, liver cancer, lung cancer and lymphoma. He speaks English, Mandarin, Hokkien and Malay, and is able to converse with his patients in these languages.
This is more than just a hospital; it's a catalyst for growth, a beacon of hope, and a testament to Bali's evolving future. Stay tuned for more updates as this exciting development unfolds!
Initial Findings: Biographies of the First Four International Doctors: A glimpse into the expertise arriving at the Bali International Hospital.
This isn't just good news for tourists seeking medical care; it's a lifeline for those battling serious illnesses, especially cancer, right here in Bali.
We extend a warm welcome to these medical pioneers and anticipate the arrival of countless individuals seeking their expertise in beautiful Sanur.
From a business perspective, drawing on 27 years of experience in Sanur, we predict this development will trigger the most significant overnight surge in demand for Sanur and neigbours real estate we've ever seen.
From a business perspective, drawing on 27 years of experience in Sanur, we predict this development will trigger the most significant overnight surge in demand for Sanur and neigbours real estate we've ever seen.
Sanur's Real Estate Boom: An Overnight Surge in Demand Predicted: Anticipating significant growth in property value near the hospital.
Properties in close proximity to the hospital will be particularly sought after.
Imagine the appeal of our Bali Luxury Villas, nestled within walking distance (a pleasant beach stroll) or a mere 5-10 minute drive, traffic permitting.
.jpg)
Bali Luxury Villas only 10-15 Min Drive or 20 -30 min Beach Walk
Start at 3 Miliar
.jpg) |
| Bali Emerald Apartments only 2,9 Juta Per Mth. Walk to Hospital |
Bali Luxury Retirement Villas. Only 15 -20 Minutes from Hospital
These stunning two-bedroom, two-bathroom residences, just 200 meters from the beach and available on an 80-year lease, start from as little as 4 Millar.
____________________________________________________________________
More Than a Hospital: A Catalyst for Growth and a Beacon of Hope: Bali's evolving future in international healthcare.
This groundbreaking development in Bali's healthcare landscape signifies more than just the establishment of a state-of-the-art medical facility. It represents a profound shift, positioning the island as a serious contender in the global medical tourism market.The influx of world-renowned specialists, particularly in critical fields like oncology, offers a beacon of hope for countless individuals in the region seeking advanced medical care without the burden of extensive and costly international travel.
Beyond the immediate healthcare benefits, this initiative promises to catalyze significant economic growth, particularly within the real estate sector in areas surrounding the hospital, creating a ripple effect of prosperity throughout the island.
As Bali embraces this new era of medical excellence, the convergence of world-class healthcare and the island's inherent allure creates a compelling proposition for investors, retirees, and those seeking quality medical treatment in a serene and healing environment.
As Bali embraces this new era of medical excellence, the convergence of world-class healthcare and the island's inherent allure creates a compelling proposition for investors, retirees, and those seeking quality medical treatment in a serene and healing environment.
.jfif)
The foresight of the Indonesian government and the collaborative spirit with Singaporean medical expertise have laid the foundation for a transformative future. May 2025, will indeed be remembered as a pivotal date, marking the dawn of Bali's healthcare revolution and the beginning of a new chapter of opportunity and hope for many.
No comments:
Post a Comment